Relmada Therapeutics (RLMD) Return on Equity [ROE] (2015 - 2026)
Relmada Therapeutics (RLMD) posted Return on Equity [ROE] of -28.80% for Q2 2026, up 326.77 percentage points from -355.57% a year earlier and up 9.48 percentage points from the prior quarter.
Powered by 
Analysis
Relmada Therapeutics (RLMD) Return on Equity [ROE] (2015 - 2026) Analysis & Trends
For FY2025, Relmada Therapeutics' Return on Equity [ROE] came in at -94.57%, up 38.39 percentage points from FY2024.
- Annual Return on Equity [ROE] shows a five-year change of -39.58 percentage points (FY2020 to FY2025).
- In prior years, Relmada Therapeutics' Return on Equity [ROE] was -132.96% in FY2024 (-45.67 pp), -87.29% in FY2023 (+5.19 pp), -92.49% in FY2022 (-12.38 pp) and -80.10% in FY2021 (-25.11 pp).
- The Q2 2026 figure stands as the highest quarterly Return on Equity [ROE] since Q2 2020.
- On a year-over-year basis, Return on Equity [ROE] has increased in each of the last three quarters, with an average year-over-year change of -21.18 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q2 2026, with a gain of 326.77 percentage points; the weakest was Q3 2025, with a drop of 281.70 percentage points.
- According to Business Quant data, Return on Equity [ROE] for the three prior quarters was -38.28% (Q1 2026), -120.25% (Q4 2025) and -442.09% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Relmada Therapeutics | 455.48 Mn | -103.11 Mn | - | -28.80% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -28.80% |
| Mar 31, 2026 | -38.28% |
| Dec 31, 2025 | -120.25% |
| Sep 30, 2025 | -442.09% |
| Jun 30, 2025 | -355.57% |
| Mar 31, 2025 | -262.95% |
| Dec 31, 2024 | -193.30% |
| Sep 30, 2024 | -160.40% |
| Jun 30, 2024 | -129.89% |
| Mar 31, 2024 | -118.85% |
| Dec 31, 2023 | -105.92% |
| Sep 30, 2023 | -104.28% |
| Jun 30, 2023 | -107.35% |
| Mar 31, 2023 | -110.99% |
| Dec 31, 2022 | -103.39% |
| Sep 30, 2022 | -85.37% |
| Jun 30, 2022 | -78.32% |
| Mar 31, 2022 | -67.11% |
| Dec 31, 2021 | -88.63% |
| Sep 30, 2021 | -131.15% |
API Access
Relmada Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=RLMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "RLMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=RLMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();